Edition:
United Kingdom

Cyclacel Pharmaceuticals Inc (CYCC.OQ)

CYCC.OQ on NASDAQ Stock Exchange Capital Market

0.64USD
5:03pm BST
Change (% chg)

$-0.01 (-1.40%)
Prev Close
$0.65
Open
$0.67
Day's High
$0.67
Day's Low
$0.61
Volume
7,292
Avg. Vol
75,570
52-wk High
$1.87
52-wk Low
$0.53

Latest Key Developments (Source: Significant Developments)

Cyclacel Pharmaceuticals Reports Q4, FY18 Results
Wednesday, 27 Mar 2019 

March 27 (Reuters) - Cyclacel Pharmaceuticals Inc ::CYCLACEL PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2018 FINANCIAL RESULTS.  Full Article

Cyclacel Pharmaceuticals Inc says No Assurance That Future Quarterly Dividends Will Be Declared
Tuesday, 12 Mar 2019 

March 12 (Reuters) - Cyclacel Pharmaceuticals Inc ::CYCLACEL PHARMACEUTICALS INC - NO ASSURANCE THAT FUTURE QUARTERLY DIVIDENDS WILL BE DECLARED.  Full Article

Cyclacel Pharmaceuticals Reports Third Quarter 2018 Financial Results
Monday, 12 Nov 2018 

Nov 12 (Reuters) - Cyclacel Pharmaceuticals Inc ::CYCLACEL PHARMACEUTICALS REPORTS THIRD QUARTER 2018 FINANCIAL RESULTS.QTRLY LOSS PER SHARE $0.91.Q3 EARNINGS PER SHARE VIEW $-0.17 -- THOMSON REUTERS I/B/E/S.CYCLACEL PHARMACEUTICALS - ESTIMATE THAT CASH RESOURCES WILL BE SUFFICIENT TO FUND OPERATIONS UNTIL Q2 OF 2020.  Full Article

Cyclacel Pharmaceuticals Says Entered Into A Common Stock Sales With H.C. Wainwright & Co, In Connection With An At Market Offering
Thursday, 4 Oct 2018 

Oct 4 (Reuters) - Cyclacel Pharmaceuticals Inc ::CYCLACEL PHARMACEUTICALS - ENTERED INTO A COMMON STOCK SALES WITH H.C. WAINWRIGHT & CO, IN CONNECTION WITH AN AT MARKET OFFERING - SEC FILING.CYCLACEL PHARMACEUTICALS INC - AS PER ATM OFFERING, CO MAY OFFER AND SELL SHARES, PAR VALUE $0.001 PER SHARE, HAVING OFFERING PRICE OF UP TO $5 MILLION.  Full Article

Cyclacel Pharma Projects Cash Resources To Fund Currently Planned Programs Through End Of 2019
Tuesday, 9 Jan 2018 

Jan 9 (Reuters) - Cyclacel Pharmaceuticals Inc ::CYCLACEL PHARMACEUTICALS INC - CO PROJECTS CASH RESOURCES TO FUND CURRENTLY PLANNED PROGRAMS THROUGH END OF 2019.  Full Article

Cyclacel Pharmaceuticals Q3 loss per share $0.91 including items
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Cyclacel Pharmaceuticals Inc ::Cyclacel Pharmaceuticals reports third quarter 2017 financial results.Q3 loss per share $0.91 including items.  Full Article